29.07.2011 • News

Linde H1 Earnings Up

Linde Group's six-month earnings attributable to Linde AG shareholders after adjusting for non-controlling interests advanced to €566 million from €445 million last year. Earnings after tax rose 23.8% to €598 million from €483 million a year ago.

In the first half of 2011, group sales improved 11% to €6.77 billion from €6.10 billion in the comparable period a year ago. After adjusting for exchange rate effects, the increase in sales was 10.3%.

Earnings per share grew by 26.2% to €3.32 from €2.63 a year earlier. On an adjusted basis, after adjusting for the effects of the purchase price allocation from the 2006 BOC acquisition, earnings per share stood at €3.79 compared with €3.15 in 2010.

The company confirmed its outlook and expects to achieve growth in group sales and group operating profit in the 2011 financial year compared with the prior year.

 

Expert Insights

ADCs for Precision Cancer Therapy
Comprehensive Insights into Antibody–Drug Conjugates

ADCs for Precision Cancer Therapy

Explore how antibody-drug conjugates are reshaping precision cancer therapy and discover what it takes to successfully develop, manufacture, and scale these complex biologics.

Article

The State of the US Specialty Chemicals Industry
Reshaping Specialty Chemicals Manufacturing

The State of the US Specialty Chemicals Industry

SOCMA's Jenn Klein examines how specialty chemical manufacturers — the invisible backbone behind pharmaceuticals, electronics, agriculture, and energy — are navigating supply chain shifts, policy uncertainty, and constant change while remaining resilient, disciplined, and focused on execution.

most read